Regulation of proteasome activity in activated human platelets

Cell Calcium

Volumn 49, Issue 4, 2011, Pages 226-232

  Nayak, Manasa K ^a   Kumar, Kailash ^a   Dash, Debabrata ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Calpain; Intracellular calcium; Platelet activation; Proteasome

Indexed keywords

CALCIMYCIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHELATING AGENT; CALPAIN; COLLAGEN; INOSITOL TRISPHOSPHATE; PROTEASOME; PROTEIN KINASE C INHIBITOR; THAPSIGARGIN; UBIQUITIN;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION;

EID: 79955098885     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.02.005     Document Type: Article

References (27)

1. Arendt C.S., Hochstrasser M. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7156-7161.
2. Rosenzweig R., Glickman M.H. Chaperone-driven proteasome assembly. Biochem. Soc. Trans. 2008, 36:807-812.
3. Ferrell K., Wilkinson C.R., Dubiel W., Gordon C. Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem. Sci. 2000, 25:83-88.
4. Glickman M.H. Getting in and out of the proteasome. Semin. Cell. Dev. Biol. 2000, 11:149-158.
5. Murata S., Sasaki K., Kishimoto T., Niwa S., Hayashi H., Takahama Y., Tanaka K. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 2007, 316:1349-1353.
6. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 1996, 30:405-439.
7. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
8. DeMartino G.N., Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 1999, 274:22123-22126.
9. Myung J., Kim K.B., Crews C.M. The ubiquitin-proteasome pathway and proteasome inhibitors. Med. Res. Rev. 2001, 21:245-273.
10. Richardson J.L., Shivdasani R.A., Boers C., Hartwig J.H., Italiano J.E. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood 2005, 106:4066-4075.
11. Falcieri E., Bassini A., Pierpaoli S., Luchetti F., Zamai L., Vitale M., Guidotti L., Zauli G. Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat. Rec. 2000, 258:90-99.
12. Yukawa M., Sakon M., Kambayashi J., Shiba E., Kawasaki T., Uemura Y., Murata R., Tanaka T., Nakayama T., Shibata H., Mori T. Purification and characterization of endogenous protein activator of human platelet proteasome. J. Biochem. 1993, 114:317-323.
13. Avcua F., Ural A.U., Cetin T., Nevruz O. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro. Thromb. Res. 2008, 121:567-571.
14. Stangl V., Lorenz M., Meiners S., Ludwig A., Bartsch C., Moobed M., Vietzke A., Kinkel H.T., Baumann G., Stangl K. Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitinproteasome pathway. FASEB J. 2004, 18:272-279.
15. Ostrowska J.K., Wojtukiewicz M.Z., Chabielska E., Buczko W., Ostrowska H. Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats. Thromb. Haemost. 2004, 92:171-177.
16. Gupta R., Chakrabarti P., Dikshit M., Dash D. Late signaling in the activated platelets upregulates tyrosine phosphatase SHP1 and impairs platelet adhesive function: regulation by calcium and Src Kinase. Biochim. Biophys. Acta. 2007, 1773:131-140.
17. Stein R.L., Melandri F., Dick L. Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry 1996, 35:3899-3908.
18. Ostrowska H., Ostrowska J.K., Worowski K., Radziwon P. Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28: a preliminary report. Platelets 2003, 14:151-157.
19. Bird G.S., Aziz O., Lievremont J.P., Wedel B.J., Trebak M., Vazquez G., Putney J.W. Mechanisms of phospholipase C-regulated calcium entry. Curr. Mol. Med. 2004, 4:291-301.
20. Watson S.P. Collagen receptor signaling in platelets and megakaryocytes. Thromb. Haemost. 1999, 82:365-376.
21. Varga-Szabo D., Braun A., Nieswandt B. Calcium signaling in platelets. J. Thromb. Haemost. 2009, 7:1057-1066.
22. Suzuki K., Hata S., Kawabata Y., Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004, 53(Suppl 1):S12-S18.
23. O'Brien C.A., Liskamp R.M., Soloman D.H., Weinstein I.B. Triphenylenes: a new class of protein kinase C inhibitors. J. Natl. Cancer 1986, 76:1243-1246.
24. Michael J., Menconi W.W., Hongmei Y., Curtis J.W., Hasselgren P.O. Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain-dependent mechanism. Surgery 2004, 136:135-142.
25. Djakovic S.N., Schwarz L.A., Barylko B., DeMartino G.N., Patrick G.N. Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 2009, 284:26655-26665.
26. Choi B.H., Hur E.M., Lee J.H., Jun D.J., Kim K.T. Protein kinase Cδ-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J. Cell. Sci. 2006, 119:1329-1340.
27. Malaver E., Romaniuk M.A., D'Atri L.P., Pozner R.G., Negrotto S., Benzadón R., Schattner M. NF-kappaB inhibitors impair platelet activation responses. J. Thromb. Haemost. 2009, 7:1333-1343.